PERIPHERAL NEUROPATHY AND NERVE ELECTROPHYSIOLOGICAL CHANGES WITH ENFORTUMAB VEDOTIN IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA: A PROSPECTIVE MULTICENTER COHORT STUDY

被引：0
|
作者：
Taoka, Rikiya
Kamada, Masaki
Izumi, Kazuyoshi
Tanimoto, Ryuta
Daizumoto, Kei
Hayashida, Yushi
Uematsu, Katsutoshi
Arai, Hironobu
Sano, Takeshi
Saito, Ryoichi
Hirama, Hiromi
Kobayashi, Toshihiro
Sugimoto, Mikio
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP53-14
引用
收藏
页码：E868 / E869
页数：2
相关论文
共 50 条
  • [1] Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
    Rikiya Taoka
    Masaki Kamada
    Kazuyoshi Izumi
    Ryuta Tanimoto
    Kei Daizumoto
    Yushi Hayashida
    Katsutoshi Uematsu
    Hironobu Arai
    Takeshi Sano
    Ryoichi Saito
    Hiromi Hirama
    Toshihiro Kobayashi
    Tomoko Honda
    Yu Osaki
    Yohei Abe
    Hirohito Naito
    Yoichiro Tohi
    Yuki Matsuoka
    Takuma Kato
    Homare Okazoe
    Nobufumi Ueda
    Mikio Sugimoto
    International Journal of Clinical Oncology, 2024, 29 : 602 - 611
  • [2] Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study
    Taoka, Rikiya
    Kamada, Masaki
    Izumi, Kazuyoshi
    Tanimoto, Ryuta
    Daizumoto, Kei
    Hayashida, Yushi
    Uematsu, Katsutoshi
    Arai, Hironobu
    Sano, Takeshi
    Saito, Ryoichi
    Hirama, Hiromi
    Kobayashi, Toshihiro
    Honda, Tomoko
    Osaki, Yu
    Abe, Yohei
    Naito, Hirohito
    Tohi, Yoichiro
    Matsuoka, Yuki
    Kato, Takuma
    Okazoe, Homare
    Ueda, Nobufumi
    Sugimoto, Mikio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (05) : 602 - 611
  • [3] Association between response to enfortumab vedotin and peripheral neuropathy in urothelial carcinoma patients: a multicenter retrospective study
    Hayakawa, Nozomi
    Kikuchi, Eiji
    Kaneko, Go
    Yamashita, Ryo
    Ikarashi, Daiki
    Endo, Yuki
    Usui, Kimitsugu
    Obara, Wataru
    Oyama, Masafumi
    Kondo, Yukihiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (11) : 1194 - 1200
  • [4] Enfortumab Vedotin in metastatic Urothelial Carcinoma: retrospective, multicenter Patient Cohort
    Darr, C.
    Zschaebitz, S.
    Niegisch, G.
    Roghmann, F.
    Ivanyi, P.
    Zengerling, F.
    Paffenholz, P.
    Biernath, N.
    Klee, M.
    Kluemper, N.
    Tauber, R.
    Hadaschik, B.
    Hilser, T.
    Gruenwald, V
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 64 - 64
  • [5] Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan
    Hara, Takuto
    Matsushita, Yuto
    Harada, Kenichi
    Fujimoto, Naohiro
    Fujisawa, Masato
    Miyake, Hideaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (06) : 696 - 698
  • [6] Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study
    Fukuokaya, Wataru
    Koike, Yuhei
    Yata, Yuji
    Komura, Kazumasa
    Uchimoto, Taizo
    Tsujino, Takuya
    Saruta, Masanobu
    Takahara, Kiyoshi
    Fujita, Kazutoshi
    Minami, Takafumi
    Adachi, Takahiro
    Hirasawa, Yosuke
    Hashimoto, Takeshi
    Ohno, Yoshio
    Uemura, Hirotsugu
    Shiroki, Ryoichi
    Azuma, Haruhito
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (04) : 342 - 347
  • [7] Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study
    Shindo, Tetsuya
    Hashimoto, Kohei
    Kenuka, Toshiki
    Miyamoto, Shintaro
    Hiyama, Yoshiki
    Fukuta, Fumimasa
    Kunishima, Yasuharu
    Okada, Manabu
    Matsukawa, Masanori
    Kato, Ryuichi
    Senda, Masaya
    Wanifuchi, Atsushi
    Sato, Shunsuke
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    JOURNAL OF GERIATRIC ONCOLOGY, 2025, 16 (02)
  • [8] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Takahashi, Shunji
    Uemura, Motohide
    Kimura, Tomokazu
    Kawasaki, Yoshihide
    Takamoto, Atsushi
    Yamaguchi, Akito
    Melhem-Bertrandt, Amal
    Gartner, Elaina M.
    Inoue, Takashi
    Akazawa, Rio
    Kadokura, Takeshi
    Tanikawa, Toshiki
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (04) : 1056 - 1066
  • [9] A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
    Shunji Takahashi
    Motohide Uemura
    Tomokazu Kimura
    Yoshihide Kawasaki
    Atsushi Takamoto
    Akito Yamaguchi
    Amal Melhem-Bertrandt
    Elaina M. Gartner
    Takashi Inoue
    Rio Akazawa
    Takeshi Kadokura
    Toshiki Tanikawa
    Investigational New Drugs, 2020, 38 : 1056 - 1066
  • [10] Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study
    Furubayashi, Nobuki
    Minato, Akinori
    Tomoda, Toshihisa
    Masaoka, Hiroyuki
    Hori, Yoshifumi
    Kiyoshima, Keijiro
    Negishi, Takahito
    Haraguchi, Yusuke
    Koga, Toshiki
    Song, Yoohyun
    Harada, Kenichi
    ANTICANCER RESEARCH, 2024, 44 (07) : 3025 - 3032
12345